New Zealand markets open in 2 hours 14 minutes

Rainmed Medical Limited (2297.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
0.3100.000 (0.00%)
At close: 10:09AM HKT

Rainmed Medical Limited

Building 31
Northeast District, Nano City No. 99 Jinji Lake Avenue Suzhou Industrial Park
Suzhou 215000
China
86 512 6262 2215
https://rainmed.com

Sector(s)Healthcare
IndustryMedical Devices
Full-time employees406

Key executives

NameTitlePayExercisedYear born
Mr. Yunfei HuoCEO & Executive Chairman of the Board2.55MN/A1979
Mr. Yonghui LyuJoint CEO & Executive Director2.71MN/A1977
Mr. Liang ZhangCFO, Joint Company Secretary & Executive Director2.69MN/A1984
Mr. Guangzhi LiuChief Technology OfficerN/AN/A1981
Mr. Ning DuanSales DirectorN/AN/AN/A
Ms. Nina ChengInternational Marketing ManagerN/AN/AN/A
Ms. Yang GuVP & Executive Director1.65MN/A1988
Mr. Kangjian LiuVP & Board SecretaryN/AN/AN/A
Mr. Xingyun WuVice PresidentN/AN/A1977
Mr. Chang ZhouVice PresidentN/AN/A1978
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HKD.

Description

Rainmed Medical Limited operates as a vascular interventional surgical robotics company in China and internationally. It engages in the research and development, manufacturing, and commercialization of medical instrument related to coronary angiography-derived fractional flow reserve (caFFR) systems and coronary angiography-derived index of microvascular resistance (caIMR) systems. The company offers caFFR systems comprising FlashAngio caFFR System and FlashPressure caFFR pressure transducer for a less-invasive physiological assessment of coronary artery ischemia severity based on coronary angiography images; and caIMR System, including FlashAngio caIMR System and FlashPressure caIMR pressure transducer, which is a less-invasive index of microcirculatory resistance measurement product for the treatment of microcirculatory lesions. It is also involved in developing intelligent angiographic injection, flash robot vascular intervention navigation operation system, and flash RDN systems. The company was founded in 2014 and is headquartered in Suzhou, China.

Corporate governance

Rainmed Medical Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.